Managing Adverse Effects of Incretin-Based Medications for Obesity

Authors:

Abstract
This JAMA Insights explores optimal strategies for managing the adverse effects associated with incretin-based medications for obesity, including semaglutide and tirzepatide.

This publication has 10 references indexed in Scilit: